06/11/2025
2:26 PM | Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
| Form SCHEDULE 13G | |
06/10/2025
7:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2025
6:50 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2025
7:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2025
7:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/20/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/19/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/12/2025
7:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for QNTM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Quantum Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
05/05/2025
9:01 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2025
8:34 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/14/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/03/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/01/2025
5:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/31/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2025
12:53 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/28/2025
5:09 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/26/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/11/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/10/2025
9:18 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/04/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/21/2025
3:00 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/17/2025
6:31 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/14/2025
7:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/07/2025
7:32 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2024
8:16 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/25/2024
6:22 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/29/2024
6:31 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/22/2024
6:54 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024
7:50 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/07/2024
6:32 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Trump wipes out trillions overnight… (Ad) Is there anybody more powerful than Donald Trump right now?
In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones…
Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move. Whether you take some of that wealth for yourself depends on if you watch this controversial exposé |
09/27/2024
7:09 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
6:27 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/09/2024
6:39 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/06/2024
8:22 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2024
8:46 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/26/2024
7:20 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 424B5 | |
08/26/2024
5:18 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024
4:18 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K/A | |
08/15/2024
7:15 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024
6:07 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
5:13 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
5:15 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K/A | |
08/12/2024
5:03 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/09/2024
6:30 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/29/2024
8:04 PM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/08/2024
4:16 PM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/08/2024
2:20 PM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2024
6:49 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024
6:34 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/13/2024
6:31 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
